Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Integra LifeSciences Holdings Corporation · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $1.79B | $1.79B - $1.79B | $204.16M | $2.863 | 6 |
| Dec 2027 | $1.73B | $1.72B - $1.74B | $197.75M | $2.611 | 7 |
| Dec 2026 | $1.68B | $1.67B - $1.69B | $191.36M | $2.438 | 7 |
| Dec 2025 | $1.63B | $1.62B - $1.65B | $186.19M | $2.201 | 7 |
| Dec 2024 | $1.61B | $1.60B - $1.63B | $184.22M | $2.452 | 8 |
| Dec 2023 | $1.57B | $1.55B - $1.58B | $178.89M | $0.303 | 7 |
| Dec 2022 | $1.56B | $1.54B - $1.57B | $322.21M | $3.313 | 4 |
| Dec 2021 | $1.54B | $1.53B - $1.56B | $300.57M | $3.177 | 5 |
| Dec 2020 | $1.37B | $1.36B - $1.39B | $256.60M | $2.354 | 5 |
| Dec 2019 | $1.52B | $1.50B - $1.53B | $209.47M | $2.738 | 4 |
| Dec 2018 | $1.47B | $1.46B - $1.48B | $219.52M | $2.39 | 9 |
| Dec 2017 | $1.17B | $1.16B - $1.19B | $130.31M | $1.858 | 14 |